Skip to content

PathVysion 02J05-030

by Abbott Molecular

Ref 02J05-030

PathVysion 02J05-030 is an in vitro diagnostic device (EU IVDD general IVD; FDA Class II; FDA product code OYU, Dna-probe kit, human chromosome) made by Abbott Molecular, registered in EUDAMED on 30 Oct 2026 (Basic UDI-DI B-00884999001855) and listed in FDA GUDID since 20 Nov 2014 (UDI-DI 00884999001855), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00884999001855 Basic UDI-DI 00884999001855UDI-DIDate30 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00884999001855 UDI-DI Date20 Nov 2014ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
ProbeChek PathVysion HER-2/neu Normal Control Slides
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00884999001855 registered 30 Oct 2026 Active
  • FDA GUDID UDI-DI 00884999001855 listed 20 Nov 2014 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Timeline

2 dated events

  1. Listed FDA GUDID 00884999001855
  2. Registered EUDAMED B-00884999001855

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
PathVysion
Generic name
Human epidermal growth factor receptor 2 (HER2) protein IVD, control
Device name
PathVysion HER-2 DNA Probe Kit
Model / Ref / Catalog
02J05-030
Primary DI / UDI-DI
00884999001855
Basic UDI-DI
B-00884999001855
FDA product code
OYU
EMDN code
W01060213, W01060214
GMDN term
Human epidermal growth factor receptor 2 (HER2) protein IVD, control
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
866.4700
EU registration type
Legacy device (under a directive)
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under ACQUIRED GENE OR CHROMOSOME ALTERATIONS.

Other devices from Abbott Molecular

See all devices from Abbott Molecular →

Properties

  • Single use
  • Contains human tissues or cells
  • Contains substances of microbial origin
  • Professional testing
  • Companion diagnostics
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)